UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfate with Cobicistate
April 14, 2014 at 08:08 AM EDT
Bristol-Myers Squibb Company (NYSE: BMY) announced today the submission of a new drug application (NDA) on April 4, 2014 to the U.S. ...
